Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The entire drug safety enterprise has a need to search, retrieve, evaluate, and synthesize scientific evidence more efficiently. This discovery and synthesis process would be greatly accelerated through access to a common framework that brings all relevant information sources together within a standardized structure. This presents an opportunity to establish an open-source community effort to develop a global knowledge base, one that brings together and standardizes all available information for all drugs and all health outcomes of interest (HOIs) from all electronic sources pertinent to drug safety. To make this vision a reality, we have established a workgroup within the Observational Health Data Sciences and Informatics (OHDSI, http://ohdsi.org) collaborative. The workgroup's mission is to develop an open-source standardized knowledge base for the effects of medical products and an efficient procedure for maintaining and expanding it. The knowledge base will make it simpler for practitioners to access, retrieve, and synthesize evidence so that they can reach a rigorous and accurate assessment of causal relationships between a given drug and HOI. Development of the knowledge base will proceed with the measureable goal of supporting an efficient and thorough evidence-based assessment of the effects of 1,000 active ingredients across 100 HOIs. This non-trivial task will result in a high-quality and generally applicable drug safety knowledge base. It will also yield a reference standard of drug-HOI pairs that will enable more advanced methodological research that empirically evaluates the performance of drug safety analysis methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Data-driven prediction of drug effects and interactions
Tatonetti, N. P., Ye, P. P., Daneshjou, R., & Altman, R. B. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003377 · Cited by 936 · cited 1×
“…the scientific literature, models that infer adverse events from graphical models of drug and conditions [40–42], and methods that use innovative approaches to overcome known limitations of drug safety sources such as spontaneous adverse event reports [18] and electronic healthcare databases [43].”
BackgroundSelf-citationDisease Ontology: a backbone for disease semantic integration
Schriml, L. M., Arze, C., Nadendla, S., Chang, Y.-W. W., Mazaitis, M., Felix, V., Feng, G., & Kibbe, W. A. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr972 · Cited by 929
The ClinicalTrials.gov Results Database — Update and Key Issues
Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1012065 · Cited by 838
Validation of a common data model for active safety surveillance research
Overhage, J. M., Ryan, P. B., Reich, C. G., Hartzema, A. G., & Stang, P. E. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000376 · Cited by 548
Self-citationMethods for Causality Assessment of Adverse Drug Reactions: A Systematic Review
Agbabiaka, T. B., Savović, J., & Ernst, E. (2008) · Drug Safety · doi:10.2165/00002018-200831010-00003 · Cited by 366
Adverse drug events: database construction and in silico prediction
Cheng, F., Li, W., Wang, X., Zhou, Y., Wu, Z., Shen, J., & Tang, Y. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci4000079 · Cited by 124 · cited 1×
“…using metabolic pathways extracted from the scientific literature, models that infer adverse events from graphical models of drug and conditions [40–42], and methods that use innovative approaches to overcome known limitations of drug safety sources such as spontaneous adverse event reports [18]…”
Method
Cited by
The role of machine learning in clinical research: transforming the future of evidence generation
Weissler, E. H., Naumann, T., Andersson, T., Ranganath, R., Elemento, O., Luo, Y., Freitag, D. F., Benoit, J., Hughes, M. C., Khan, F., et al. (2021) · Trials · doi:10.1186/s13063-021-05489-x · Cited by 280
A curated and standardized adverse drug event resource to accelerate drug safety research
Banda, J. M., Evans, L., Vanguri, R. S., Tatonetti, N. P., Ryan, P. B., & Shah, N. H. (2016) · Scientific Data · doi:10.1038/sdata.2016.26 · Cited by 246
Self-citationUsing electronic health records for clinical research: the case of the EHR4CR project
De Moor, G., Sundgren, M., Kalra, D., Schmidt, A., Dugas, M., Claerhout, B., Karakoyun, T., Ohmann, C., Lastic, P.-Y., Ammour, N., et al. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.10.006 · Cited by 181
A Census of Disease Ontologies
Haendel, M. A., McMurry, J. A., Relevo, R., Mungall, C. J., Robinson, P. N., & Chute, C. G. (2018) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-080917-013459 · Cited by 49
Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance
Norén, G. N., Caster, O., Juhlin, K., & Lindquist, M. (2014) · Drug Safety · doi:10.1007/s40264-014-0198-z · Cited by 40
Self-citation
Metadata
- Authors
- Boyce, R. D., Ryan, P. B., Norén, G. N., Schuemie, M. J., Reich, C., Duke, J., Tatonetti, N. P., Trifirò, G., Harpaz, R., Overhage, J. M., Hartzema, A. G., Khayter, M., Voss, E. A., Lambert, C. G., Huser, V., & Dumontier, M.
- Venue
- Drug Safety
- Published
- 2014-07-02
- Volume
- 37
- Issue
- 8
- Pages
- 557-567
- ISSN
- 0114-5916 (ISSN-L)
- 1179-1942
- OpenAlex
- W2134793292
- Cited by
- 49
- References
- 7
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest. https://app.cochat.ai/papers/10.1007/s40264-014-0189-0
- The paper
- Boyce, R. D., Ryan, P. B., Norén, G. N., Schuemie, M. J., Reich, C., Duke, J., Tatonetti, N. P., Trifirò, G., Harpaz, R., Overhage, J. M., Hartzema, A. G., Khayter, M., Voss, E. A., Lambert, C. G., Huser, V., & Dumontier, M. (2014). Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest. Drug Safety. https://doi.org/10.1007/s40264-014-0189-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.